Cite
HARVARD Citation
Korman, N. et al. (2017). Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis. Journal of dermatological treatment. pp. 384-389. [Online].